Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behçet's disease

FEMS Immunology and Medical Microbiology

Volumn 43, Issue 2, 2005, Pages 125-131

  Kurauchi, Tomomi ^a   Yokota, Kenji ^a   Matsuo, Toshihiko ^a   Fujinami, Yoshihito ^a   Isogai, Emiko ^b   Isogai, Hiroshi ^c   Ohtsuki, Hiroshi ^a   Oguma, Keiji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adamantiades Behcet's disease; Chemiluminescence; IFN ; IL 12; IL 8; Neutrophil; Streptococcus sanguinis; T helper 1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 8;

ADAMANTIADES BEHCET DISEASE; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BEHCET DISEASE; BLOOD; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL ULCER; HEALTH STATUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; MALE; MONONUCLEAR CELL; MOUTH ULCER; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; STREPTOCOCCUS; TH1 CELL; UVEITIS; VOLUNTEER;

ADULT; AGED; BEHCET SYNDROME; CELLS, CULTURED; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERSENSITIVITY; INTERFERON TYPE II; INTERLEUKINS; LYMPHOCYTES; MALE; MIDDLE AGED; MOUTH; NEUTROPHILS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SANGUIS;

EID: 12844273711     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.07.007     Document Type: Article

References (24)

1. K. Aoki, and S. Choo Studies on the construction and past history of patients with Behçet's disease Acta Soc. Ophthalmol. 76 1972 1608 1612
2. D.K. Martin, D.C. Nelms, B.F. Mackler, and D.L. Peavy Lymphoproliferative responses induced by streptococcal antigens in recurrent aphthous stomatitis and Behçet's syndrome Clin. Immunol. Immunopathol. 13 1979 146 155
3. The Behçet's Disease Committee of Japan. (1989) Skin hypersensitivity to Streptococcus antigens and the induction of symptoms by the antigens in Behçet's disease. J Rheumatol. 16, 506-511
4. E. Isogai, S. Ohno, K. Takeshi, K. Yoshikawa, T. Tsurumizu, H. Isogai, K. Yokota, S. Kotake, Y. Sakamoto, H. Shimizu, H. Matsuda, M. Yamaguchi, and K. Oguma Close association of Streptococcus sanguis uncommon serotypes with Behçet's disease Bifidobacteria Microflora. 9 1990 27 41
5. K. Yokota, S. Hayashi, N. Fujii, K. Yoshikawa, S. Kotake, E. Isogai, S. Ohno, Y. Araki, and K. Oguma Antibody response to oral Streptococci in Behçet's disease Microbiol. Immunol. 36 1992 815 822
6. K. Yokota, and K. Oguma IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behçet's disease Microbiol. Immunol. 41 1997 925 931
7. H. Direskeneli Behçet's disease: infections aetiology, new autoantigens, and HLA-B51 Ann. Rheum. Dis. 60 2001 996 1002
8. T. Sakane, M. Takeno, N. Suzuki, and G. Inada Behçet's disease New Engl. J. Med. 341 1999 1284 1291
9. K.S. Doran, J.C. Chang, V.M. Benoit, L. Eckmann, and V. Nizet Group B Streptococcal β-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8 J. Infect. Dis. 185 2002 196 203
10. A. Wanahita, E.A. Goldsmith, D.M. Musher, J.E. Clarridge III, J. Rubio, B. Krishnan, and J. Trial Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria J. Infect. Dis. 185 2002 85 90
11. C. Mantas, H. Direskeneli, D. Oz, S. Yavuz, and T. Akoglu IL-8 producing cells in patients with Behçet's disease Clin. Exp. Rheumatol 18 2000 249 251
12. C.C. Zouboulis, J. Katsantonis, R. Ketteler, R. Treudler, E. Kaklamani, S. Hornemann, P. Kaklamanis, and C.E. Orfanos Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells Arch. Dermatol. Res. 292 2000 279 284
13. J. Katsantonis, Y. Adler, C.E. Orfanos, and C.C. Zouboulis Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate Dermatology 201 2000 37 39
14. G.H.W. Bowden, D.C. Ellwood, and I.R. Hamilton Microbial ecology of the oral cavity Adv. Microb. Ecol. 3 1979 135 217
15. E.V. Frandsen, V. Pedrazzoli, and M. Kilian Ecology of viridans Streptococci in the oral cavity and pharynx Oral Microbiol. Immunol. 6 1991 129 133
16. N. Sugi-Ikai, M. Nakazawa, S. Nakamura, S. Ohno, and M. Minami Increased frequencies of interleukin-2 and interferon-gamma producing T cells in patients with active Behçet's disease (BD) and recurrent aphthous stomatitis (RAS) Clin. Exp. Immunol. 118 1999 451 457
17. M.A. Frassanito, R. Dammacco, P. Cafforio, and F. Dammacco Th-1 polarization of the immune response in Behçet's disease: a putative pathogenic role of interleukin-12 Arthritis Rheum. 42 1999 1967 1974
18. B. Turan, H. Gallati, H. Erdi, A. Gurler, B.A. Michel, and P.M. Villiger Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity J. Rheumatol. 24 1997 128 132
19. S. Raziuddin, A. al-Dalaan, S. Bahabri, A.K. Siraj, and S. al-Sedairy Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern J. Rheumatol. 25 1998 329 333
20. T. Lehner, E. Lavery, R. Smith, R. van der Zee, Y. Mizushima, and T. Shinnick Association between the 65-kilodalton heat shock protein Streptococcus sanguis and the corresponding antibodies in Behçet's syndrome Infect. Immun. 59 1991 1434 1441
21. H. Direskeneli, G. Keser, D. D'Cruz, M.A. Khamashta, T. Akoglu, H. Yazici, S. Yurdakul, V. Hamuryudan, S. Ozgun, and A.J. Goral Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease Clin. Rhuematol. 14 1995 55 61
22. B. Celet, G. Akman-Demir, P. Serdaroglu, S.P. Yentur, B. Tasci, van Noort J.M, M. Eraksoy, and G. Saruhan-Direskeneli Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases J. Neurol. 247 2000 935 939
23. B.C. Aridogan, M. Yildirim, V. Baysal, H.S. Inaloz, K. Baz, and S. Kaya Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease J. Dermatol. 30 2003 602 607
24. M. Misumi, E. Hagiwara, M. Takeno, Y. Takeda, Y. Inoue, T. Tsuji, A. Ueda, S. Nakamura, S. Ohno, and Y. Ishigatsubo Cytokine production profile in patients with Behçet's disease treated with infliximab Cytokine 24 2003 210 218